Salix Price RAISED to Reflect Solesta Introduction and 3 Must-See Stock Analyses

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) price target was raised by Susquehanna due to its Solesta drug’s opportunity as well as its upcoming  Relistor PDUFA date. The shares have a Positive rating.

Molycorp, Inc Common Stock $0.0 (NYSE:MCP) price target was reduced by JPMorgan because of the company’s Neo Materials acquisition. The firm shows concerns regarding the price Molycorp paid is too high if rare earth prices fall as expected. The firm maintains a Neutral rating on the shares.

Don’t Miss: Sirius: We’re Too Busy Being Awesome.

Mellanox Technologies, Ltd. (NASDAQ:MLNX): ThinkEquity predicts more evidence of Mellanox’s InfiniBand’s expansion to both enterprise customers and Web 2.0 datacenters. The firm keeps a Buy rating on the stock.

Enterprise Products Partners LP (NYSE:EPD): According to UBS, NGL price weakness may cause more surprises for natural gas gathering and processing companies, but continues its recommendation of top picks Enterprise Products and Plains All American (NYSE:PAA) due to strong distribution growth and many projects.

LSI Corporation (NYSE:LSI) had its earnings estimates lowered by FBR due to weak demand for hard disk drives, but the firm believes the stock is greatly pricing in the current levels of its risks. The firm views LSI as a buying opportunity, but reduced its price target from $11.50 to $10.

Don’t Miss: Samsung Scores An EMBARRASSING Win Over Apple.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.